Relmada Therapeutics
RLMD----
Relmada Therapeutics (RLMD)
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controll...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Relmada Therapeutics Analyst Rating
View MoreForecast & Rating
Jun 23, 2026Price forecast
$12.67143.59%
Forecast & RatingStrong buy
6analysts
- Strong buy83.33%
- Buy16.67%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · Jul 17 at 06:40 AM
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Sees Significant Growth in Short Interest
- StockTitan · Jul 15 at 10:05 PM
Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 | RLMD Stock News
- benzinga_article · Jun 29 at 06:08 AM
Relmada Therapeutics Joins Russell 2000 Index And Russell 3000 Index
- benzinga_article · Jun 18 at 12:38 PM
Relmada's Cancer Drug Candidate Sparks Fresh Bullish Call
- benzinga_article · Jun 18 at 06:45 AM
This Talen Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
- benzinga_article · Jun 3 at 07:29 AM
Marvell Technology Soars on NVIDIA CEO's Endorsement, Joins Relmada Therapeutics and Other Big Stocks Moving Higher in Wednesday's Pre-Market Session
